Vifor Pharma AG (VIFN:SW) (GNHAY) PT Raised to CHF127 at UBS
Tweet
Share
E-mailGet Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 68
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 68
Trade Now!
Join SI Premium – FREE
UBS analyst Laura Sutcliffe raised the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF127.00 (from CHF119.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Oji Holdings Corp (3861:JP) (OJIPY) PT Raised to JPY810 at Nomura/Instinet
- Nestle India Ltd (NEST:IN) PT Lowered to INR12,905 at Goldman Sachs
- Rieter Holding AG (RIEN:SW) PT Raised to CHF124 at Credit Suisse
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
